Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.

Fraune C, Lange S, Krebs C, Hölzel A, Baucke J, Divac N, Schwedhelm E, Streichert T, Velden J, Garrelds IM, Danser AH, Frenay AR, van Goor H, Jankowski V, Stahl R, Nguyen G, Wenzel UO.

Am J Physiol Renal Physiol. 2012 Oct;303(7):F1037-48. doi: 10.1152/ajprenal.00672.2011. Epub 2012 Jul 11.

PMID:
22791343
[PubMed - indexed for MEDLINE]
Free Article
2.

[Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].

Horký K.

Vnitr Lek. 2007 Apr;53(4):364-70. Review. Czech.

PMID:
17578167
[PubMed - indexed for MEDLINE]
3.

Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.

Sepehrdad R, Frishman WH, Stier CT Jr, Sica DA.

Cardiol Rev. 2007 Sep-Oct;15(5):242-56. Review.

PMID:
17700383
[PubMed - indexed for MEDLINE]
4.

Direct renin inhibition--a promising strategy for renal protection?

Lizakowski S, Tylicki L, Rutkowski B.

Med Sci Monit. 2013 Jun 12;19:451-7. doi: 10.12659/MSM.883949. Review.

PMID:
23756824
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.

Expert Opin Pharmacother. 2007 Apr;8(5):529-35. Review.

PMID:
17376010
[PubMed - indexed for MEDLINE]
6.

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.

Verdecchia P, Angeli F, Mazzotta G, Gentile G, Reboldi G.

Vasc Health Risk Manag. 2008;4(5):971-81. Review.

PMID:
19183745
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].

Horký K.

Vnitr Lek. 2010 Feb;56(2):120-6. Review. Czech.

PMID:
20329582
[PubMed - indexed for MEDLINE]
8.

Renin inhibition in hypertension.

Gradman AH, Kad R.

J Am Coll Cardiol. 2008 Feb 5;51(5):519-28. doi: 10.1016/j.jacc.2007.10.027. Review.

PMID:
18237679
[PubMed - indexed for MEDLINE]
Free Article
9.

The renin inhibitor aliskiren as novel treatment for cardiovascular disease.

Saez AO, Philipp T, Nürnberger J.

Recent Pat Cardiovasc Drug Discov. 2006 Nov;1(3):233-40. Review.

PMID:
18221088
[PubMed - indexed for MEDLINE]
10.

Direct renin inhibition: clinical pharmacology.

Azizi M.

J Mol Med (Berl). 2008 Jun;86(6):647-54. doi: 10.1007/s00109-008-0329-z. Epub 2008 Mar 27. Review. Retraction in: J Mol Med (Berl). 2012 Apr;90(4):465.

PMID:
18368379
[PubMed - indexed for MEDLINE]
11.

Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?

Gerc V, Buksa M, Loza V, Kulic M.

Med Arh. 2009;63(6):343-9. Review.

PMID:
20380117
[PubMed - indexed for MEDLINE]
12.

Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions.

Angeli F, Reboldi G, Mazzotta G, Poltronieri C, Garofoli M, Ramundo E, Biadetti A, Verdecchia P.

Curr Drug Saf. 2012 Feb;7(1):76-85. Review.

PMID:
22663961
[PubMed - indexed for MEDLINE]
13.

Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.

Dalla Vestra M, Simioni N, Masiero A.

Minerva Endocrinol. 2009 Dec;34(4):333-8. Review.

PMID:
20046162
[PubMed - indexed for MEDLINE]
14.

Aliskiren, the future of renin-angiotensin system blockade?

Uresin Y, Mehtar Bozkurt M, Sabirli S, Ozunal ZG.

Expert Rev Cardiovasc Ther. 2007 Sep;5(5):835-49. Review.

PMID:
17867914
[PubMed - indexed for MEDLINE]
15.

Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases.

Yarows SA.

Expert Rev Cardiovasc Ther. 2010 Jan;8(1):19-33. Review.

PMID:
20030022
[PubMed - indexed for MEDLINE]
16.

Recent changes in the landscape of combination RAS blockade.

Epstein BJ, Smith SM, Choksi R.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127. Review.

PMID:
19900020
[PubMed - indexed for MEDLINE]
17.

Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunities.

Volpe M, Pontremoli R, Borghi C.

High Blood Press Cardiovasc Prev. 2011 Sep 1;18(3):93-105. doi: 10.2165/11593540-000000000-00000. Review.

PMID:
21950781
[PubMed - indexed for MEDLINE]
18.

New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.

Feldman DL.

Hypertens Res. 2010 Apr;33(4):279-87. doi: 10.1038/hr.2010.19. Epub 2010 Mar 5. Review.

PMID:
20203685
[PubMed - indexed for MEDLINE]
19.

Potential benefits of aliskiren beyond blood pressure reduction.

Weintraub HS, Tran H, Schwartzbard A.

Cardiol Rev. 2011 Mar-Apr;19(2):90-4. doi: 10.1097/CRD.0b013e318204d9ae. Review.

PMID:
21285669
[PubMed - indexed for MEDLINE]
20.

Aliskiren: the first direct renin inhibitor available for clinical use.

Morganti A, Lonati C.

J Nephrol. 2011 Sep-Oct;24(5):541-9. doi: 10.5301/jn.5000008. Review.

PMID:
21786226
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk